Haemophilus influenzae Type b

Haemophilus b Vaccine GSK

Haemophilus Infections

Haemophilus b Vaccine Aventis

Haemophilus b Vaccine Lederle

FDA approves GlaxoSmithKline's new combo vaccine MenHibrix

The US Food and Drug Administration has approved US pharma giant GlaxoSmithKline's (LSE: GSK) MenHibrix (meningococcal groups C and Y and Haemophilus b tetanus toxoid conjugate vaccine), a combination...

FDA approves GSK vaccine for meningitis-tied bacteria in children

GlaxoSmithKline received FDA approval of MenHibrix, a vaccine against Haemophilus influenzae and Neisseria meningitidis in ch -More- 

ACIP Issues New Hib Statement

(MedPage Today) -- The Advisory Committee on Immunization Practices has approved the first statement on routine Haemophilus influenzae type b (Hib) vaccination since 1993.

Pending EC decision: Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Opinion date: 21-Feb-2013

Pending EC decision: Hexyon, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Opinion date: 21-Feb-2013

Human medicines European Public Assessment Report (EPAR): Hexavac, diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted, Revision: 0, Withdraw

Human medicines European Public Assessment Report (EPAR): Hexavac, diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis b (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted, Revision: 0, Withdrawn

FDA OKs Vaccine Against 2 Causes of Meningitis

WASHINGTON (MedPage Today) -- The FDA has approved a new combination vaccine for prevention of meningococcal disease and Haemophilus influenzae type b disease in infants and young children.

Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction.

SUMMARY We assessed the impact of Haemophilus influenzae type b (Hib) vaccination, introduced in France in early 1993, on the incidence of invasive Haemophilus influenzae (Hi) disease up to 2008. The...

Haemophilus influenzae Outer Membrane Protein P6 Molecular Characterization May Not Differentiate All Strains of H. Influenzae From H. haemolyticus.

Distinguishing non-typeable Haemophilus influenzae and Haemophilus haemolyticus by omp P6 sequencing is complicated by sequence variants in isolates. Further testing using RapID NH and multi-locus seq...

Descending thoracic aortitis due to Haemophilus influenzae: a case report and literature review.

Aortitis due to Haemophilus influenzae especially involving the descending thoracic aorta is rarely encountered. We present a case and literature review concerning Haemophilus influenzae aortitis. Thi...

Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination.

Haemophilus influenzae type b vaccine was introduced into the Immunization Program of Brazil in 1999 and no study has evaluated the impact of Hib vaccination in H. influenzae carriage so far. In June...

Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco.

Haemophilus influenzae type b (Hib) is a leading cause of bacterial meningitis and pneumonia and can be prevented by Hib vaccine. We conducted a vaccine impact evaluation to support continued use of H...